Economic evaluation of statins in high-risk patients treated for primary and secondary prevention of cardiovascular disease in Greece

about

Systematic Review of Validity Assessments of Framingham Risk Score Results in Health Economic Modelling of Lipid-Modifying Therapies in Europe.

P2860

Q47698675-D15BEC04-BBCC-418A-A5E3-E88AF3677EE4

P2860

Economic evaluation of statins in high-risk patients treated for primary and secondary prevention of cardiovascular disease in Greece

Item

http://www.wikidata.org/entity/Q36039663

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

Economic evaluation of statins ...... rdiovascular disease in Greece

@ast

Economic evaluation of statins ...... rdiovascular disease in Greece

@en

type

Item

label

Economic evaluation of statins ...... rdiovascular disease in Greece

@ast

Economic evaluation of statins ...... rdiovascular disease in Greece

@en

prefLabel

Economic evaluation of statins ...... rdiovascular disease in Greece

@ast

Economic evaluation of statins ...... rdiovascular disease in Greece

@en

P1476

Economic evaluation of statins ...... rdiovascular disease in Greece

@en

P2093

Georgia Kourlaba

http://www.w3.org/2001/XMLSchema#string

Nikolaos Maniadakis

http://www.w3.org/2001/XMLSchema#string

Vassilis Fragoulakis

http://www.w3.org/2001/XMLSchema#string

P2860

Quantifying effect of statins on low density lipoprotein cholesterol, ischaemic heart disease, and stroke: systematic review and meta-analysis

Prevalence, and associated risk factors, of self-reported diabetes mellitus in a sample of adult urban population in Greece: MEDICAL Exit Poll Research in Salamis (MEDICAL EXPRESS 2002)

Prevalence of self-reported hypertension and its relation to dietary habits, in adults; a nutrition & health survey in Greece

Self-reported prevalence of atherothrombosis in a general population sample of adults in Greece; a telephone survey.

Comparative dose efficacy study of atorvastatin versus simvastatin, pravastatin, lovastatin, and fluvastatin in patients with hypercholesterolemia (the CURVES study)

Age-associated cardiovascular changes in health: impact on cardiovascular disease in older persons.

Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project.

The cost-effectiveness of a new statin (rosuvastatin) in the UK NHS.

Rosuvastatin: a new inhibitor of HMG-coA reductase for the treatment of dyslipidemia.

Economic evaluation of treatment strategies for patients suffering acute myocardial infarction in Greece.

P304

135-143

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2147/CEOR.S31376

http://www.w3.org/2001/XMLSchema#string

P407

English

P478

http://www.w3.org/2001/XMLSchema#string

P577

2012-05-29T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

227711309

http://www.w3.org/2001/XMLSchema#string

P698

22719213

http://www.w3.org/2001/XMLSchema#string

P932

3377435

http://www.w3.org/2001/XMLSchema#string

Economic evaluation of statins in high-risk patients treated for primary and secondary prevention of cardiovascular disease in Greece

about

P2860

P2860

Economic evaluation of statins in high-risk patients treated for primary and secondary prevention of cardiovascular disease in Greece

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P478

P577

P5875

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P478

P577

P5875

P698

P932